Returtutide bụ otu ụdị nke ndị mejupụtara 39 amino acids site na amịrị na-eme ihe nkiri na-akpali GLP-1, gip, na GCGS
Ọ bụ usoro ọgwụgwọ nke Grimeton (GLP-1, Gip, na GCG ndị na-echepụta ihe karịrị 17.5% na-enweghị oke ibu ma ọ bụ ibu (buru ibu) n'oge ọnwụnwa. Na ikpe ahụ, ndị sonyere natara nke kachasị elu (12 mg) gosipụtara mbelata ibu nke 24.2% mgbe izu 48 gachara.
Returtutide bụ ihe aelonide na-eme ihe ngosi nke na-echeta ndị na-anabata ya, ọrịa gastric na-egbochi, na gricagon {{6} 1 {6} 1. Usoro ihe dị mgbagwoju anya nke ime ihe na-agụnye mmekọrịta ndị na-anabata ihe ndị a, na-ebute na nzuzo insulin, na-eme ka usoro glacose na-abawanye mma, na mgbanwe agụụ. Ọgwụgwọ nnwale na-arụsi ọrụ ike na Friments 1 ruo 3 gosipụtara oke arụmọrụ, nke na-egosiputa ihe dị oke mkpa na nsonaazụ Glycemic. Additionally, retatrutide shows promise in mitigating cardiovascular risk factors and addressing metabolic dysfunction-associated steatotic liver disease. Agbanyeghị, a chọrọ nlebara anya nke ọma na profaịlụ nchekwa nke ogologo oge ya, nyochaa ikike ya nwere na ndị obodo pụrụ iche, tụgharịa ikike ọgwụgwọ ọgwụgwọ, ma na-elitud usoro ya na penort na-arịa ụmụ. Dịka ọnọdụ ọgwụgwọ ọpụpụ, resatututide na-anọchi anya olileanya nke olileanya, mgbanwe mgbanwe mgbanwe nke oke ibu (T2DM), na ikike ịgagharị na nchịkwa. Nyochaa akụkọ a na-enyocha oke ọgwụgwọ nke ịzụ ahịa na njikwa oke ibu na t2dm.
Ngosipụta Ngwaahịa

Nkọwa nyocha



Nzaghachi ndị ahịa

Okwu Mmeghe


Nkwakọ ngwaahịa na njem


Uru Anyị
Ogo dị elu, ọnụahịa asọmpi, ngwaahịa zuru oke na ọnụahịa nnyefe asọmpi ngwa ngwa.
Standard Standard na divest 99%.
Anyị bụ ndị nrụpụta ma nwee ike ịnye ngwaahịa dị mma na ọnụahịa ụlọ ọrụ.
Nnyefe na nnyefe ngwa ngwa
1) Enwere ike izipu ngwugwu 1 na ụbọchị ọrụ 3 mgbe ịkwụ ụgwọ. Nọmba nsuso dị.
2) Mbupu na nke nwere uche. ụzọ njem dị iche iche maka nhọrọ gị.
3) Customs Amezunala na-agafe 99%
Ajụjụ
Ihe nchịkọta dị ọkụ: Ntinye ego nke 10mg 10mg 30mg 30mg 30mg 30, China na-akwụ ụgwọ 5mg 10mg 15mg 15mg 30mg 30 na-emepụta ihe, ndị na-eweta ihe







